FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4945

FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma

Analysis of PDA tumors isolated from KPC (LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre) mice after combined treatment with FG-3019 (a mAb directed against CTGF) and chemotherapy drug gemcitabine. Results provide insight into the molecular basis of the enhanced anti-PDA activity of FG-3019/gemcitabine.

Organism:: Mus musculus

Type:: Expression profiling by array, count, 4 protocol sets

Platform:: GPL8321
Series:: GSE46203
24 Samples

Download data: CEL

DataSet

Accession:: GDS4945

ID:: 4945

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal ...
FG-3019/gemcitabine combined-treatment effect on KPC model of pancreatic ductal adenocarcinoma
Accession: GDS4945

GEO DataSets
Related DataSets for GEO Profiles (Select 114334746) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets